Skip to main content

Intra-Cellular Therapies, Inc.

ITCIDelisted Apr 2, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001567514

Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Intra-Cellular Therapies, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of ITCI: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders3568387+39
Shares97.2M849.8K96.8M+437.4K (+0.5%)
Value$7.12B$73.5M$8.08B+$1.03B (+14.6%)

8 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (69)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ITCI in Q4 2024
InstitutionSharesValue% of portfolio
Raymond James Financial Inc915,361$76.5M0.03%
OrbiMed Advisors LLC163,000$13.6M0.28%
Ally Bridge Group (NY) LLC147,750$12.3M10.58%
Two Sigma Advisers, LP143,267$12.0M0.03%
Balyasny Asset Management LLC139,660$11.7M0.03%
Citadel Advisors LLC118,021$9.86M0.01%
Universal- Beteiligungs- und Servicegesellschaft mbH95,200$7.95M0.02%
Patient Square Capital LP71,990$6.01M2.25%
Verition Fund Management LLC45,212$3.78M0.02%
Moore Capital Management, LP40,000$3.34M0.06%
Police & Firemen's Retirement System of New Jersey37,127$3.10M0.03%
F/M Investments LLC36,920$3.08M0.11%
1832 Asset Management L.P.20,700$1.73M0.00%
KLP Kapitalforvaltning AS20,500$1.71M0.01%
Raiffeisen Bank International AG17,000$1.42M0.02%
Fox Run Management, L.L.C.16,667$1.39M0.25%
Susquehanna Fundamental Investments, LLC16,307$1.36M0.02%
ExodusPoint Capital Management, LP14,239$1.19M0.01%
ING Groep NV12,500$1.04M0.01%
Inceptionr LLC12,375$1.03M0.23%
Cookson Peirce & Co Inc11,670$974.7K0.04%
Atom Investors LP9,309$777.5K0.10%
Mercer Global Advisors Inc7,471$624.0K0.00%
Jain Global LLC7,280$608.0K0.02%
Panagora Asset Management Inc6,843$571.5K0.00%
Alpha DNA Investment Management LLC5,797$484.2K0.26%
Aquatic Capital Management LLC5,206$434.8K0.01%
Two Sigma Securities, LLC4,639$387.4K0.07%
Occudo Quantitative Strategies LP4,539$379.1K0.07%
Brown Advisory Inc4,261$355.9K0.00%
ClearAlpha Technologies LP3,981$332.5K0.29%
Tema ETFs LLC3,388$283.0K0.12%
Barlow Wealth Partners, Inc.2,200$278.8K0.04%
Quantinno Capital Management LP3,062$255.7K0.00%
Avanza Fonder AB3,043$254.2K0.01%
Bayforest Capital Ltd3,032$253.2K0.32%
Maverick Capital LtdSuperinvestorMaverick Capital3,005$251.0K0.00%
PEAK6 LLC3,000$250.6K0.01%
Everence Capital Management Inc2,990$250.0K0.02%
Point72 (DIFC) Ltd2,952$246.5K0.02%
Fulton Bank, N.A.2,802$234.0K0.01%
Wealthspire Advisors, LLC2,622$219.0K0.00%
Merit Financial Group, LLC2,465$205.9K0.00%
R Squared Ltd2,450$204.6K0.20%
GF Fund Management Co. Ltd.2,226$185.9K0.00%
Venturi Wealth Management, LLC1,150$96.0K0.00%
Caitong International Asset Management Co., Ltd543$45.4K0.04%
WPG Advisers, LLC432$36.1K0.03%
Accredited Wealth Management, LLC335$28.0K0.02%
Coppell Advisory Solutions LLC282$23.5K0.00%
Ameriflex Group, Inc.160$20.3K0.01%
Steward Partners Investment Advisory, LLC241$20.1K0.00%
MAI Capital Management174$14.5K0.00%
Colonial Trust Co143$11.9K0.00%
Sherman Asset Management, Inc.110$9.19K0.01%
Aster Capital Management (DIFC) Ltd74$6.18K0.00%
Meeder Asset Management Inc53$4.43K0.00%
Kestra Investment Management, LLC52$4.34K0.00%
Avalon Trust Co45$3.76K0.00%
Skopos Labs, Inc.25$2.09K0.00%
CIBC Private Wealth Group, LLC19$1.57K0.00%
Aventura Private Wealth, LLC18$1.50K0.00%
Spire Wealth Management13$1.09K0.00%
Cassady Schiller Wealth Management, LLC13$1.09K0.00%
Bokf, NA10$9490.00%
Cornerstone Planning Group LLC7$8900.00%
SBI Securities Co., Ltd.10$8350.00%
Brown Brothers Harriman & Co7$5850.00%
Larson Financial Group LLC2$1670.00%

Sold out (30)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (8)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ITCI in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Eagle Asset Management Inc624,759$57.0M
Raymond James & Associates158,852$11.6M
B. Metzler seel. Sohn & Co. Holding AG33,291$2.44M
Chartwell Investment Partners, LLC13,270$971.0K
ClariVest Asset Management LLC8,164$559.2K
Raymond James Financial Services Advisors, Inc.4,197$307.1K
PEAK6 Investments LLC4,049$296.3K
Raymond James Trust N.A.3,199$234.1K